Parsons, W.B. , JR.: Treatment of hypercholesterolemia by nicotinic acid. A. M. A. Arch. Int. Med., 107: 639, 1961 .
2.
Steinberg, D. , Avigan, J., and Feigelson, B.: Effects of triparanol (MER-29) on cholesterol biosynthesis and on blood sterol levels in man. J. Clin. Invest ., 40: 884, 1961.
3.
Hashim, S.A. , Bergen, S., JR., and Van Italli , T.B.: Experimental steatorrhea induced in man by bile acid sequestrant. Proc. Soc. Exper. Biol. & Med., 106: 173, 1961.
4.
Dale, H.H.: Chemical structure and physiological action. Bull. Johns Hopkins Hosp., 31: 356, 1920.
5.
Rawson, R.W. , Money, W.L., Krock , R.L., Kumaoha, S., Benna, R.S., and Leeper, R.D.: Dissociation of thyroid hormonal effects by structural alterations of the thyroxine molecule . Am. J. M. Sc., 238: 261, 1959.
6.
Best, M.M., and Duncan, C.H.: Effect of tetraiodothyroformic acid on oxygen consumption of the cholesterol-thiouracil-fed rat. Am. J. Physiol., 196: 857, 1959.
7.
Boyd, G.S., and Oliver, M.F.: Various effects of thyroxine analogues on the heart and serum cholesterol in the rat. J. Endocrinol., 21: 25, 1960.
8.
Starr, P., Roen, P., Freibrun, J.L., and Schleissner, L.: Reduction of serum cholesterol by sodium dextro-thyroxine. Arch. Intern. Med., 105: 830, 1960.
9.
Starr, P.: Maintenance of normal metabolism in athyreotic patients by sodium dextrothyroxine . Acta endocrinol., 37: 110, 1961.
10.
Starr, P.: Therapeutic value of sodium dextro-thyroxine. Clin. Pharmacol. Ther., 1: 716, 1960.
11.
Hoobler, S., Caldwell, C., and Beier-Waltes, W.H. : Cholesterol disappearance in rodents. Symposium on D-Thyroxine p. 43. Travenol Laboratories, Morton Grove, Illinois, 1959.
12.
RABINOWITZ, J. L.: Personal communication.
13.
Starr, P.: Sodium dextrothyroxine and sodium levothyroxine: results of their use in an athyreotic patient with angina pectoris and hypercholesterolemia . J. A. M. A., 173: 1934, 1960.
